Literature DB >> 21331743

A Japanese case of proteinase 3 antineutrophil cytoplasmic autoantibody-associated pauci-immune-type crescentic glomerulonephritis without valvular endocarditis.

Satoshi Morimoto1, Fumitaka Nakajima2, Tatsuyori Morita3, Kazunori Someya3, Makiko Kusabe3, Mitsutaka Nakahigashi3, Takatomi Yurugi3, Masayoshi Fukui2, Takayuki Okamoto2, Fusakazu Jo3, Nagaoki Toyoda3, Toshiji Iwasaka3.   

Abstract

A 74-year-old male without recent medical treatment visited our hospital complaining of fever and lack of appetite. Upon examination severe azotemia, proteinuria, and urinary occult blood were noted, and the patient was admitted. Results of a blood test showed that his proteinase 3 antineutrophil cytoplasmic autoantibody (PR3-ANCA) level was high. A transthoracic echocardiogram indicated normal cardiac function and no valvular regurgitation or stenosis. Necrotizing glomerulonephritis accompanied by cellular crescentic bodies, but not granuloma, was noted on renal biopsy. An immunofluorescence study demonstrated no immunofluorescence staining in the glomerulus or in the tubulointerstitial or vascular compartments. No lesion was present in the lung or upper respiratory tract. The patient was diagnosed with PR3-ANCA-associated pauci-immune-type crescentic glomerulonephritis and treated with steroids. This treatment resulted in rapid normalization of C-reactive protein, and the PR3-ANCA level slowly decreased and converted to negative. The renal function, however, did not improve, and maintenance dialysis was introduced. No pulmonary or upper airway lesion has developed during 18 months of follow-up. PR3-ANCA-positive crescentic glomerulonephritis accompanied by valvular endocarditis has been described by several reports in Japan; however, this case was not complicated by valvular endocarditis. To our knowledge, this is the 4th case report describing PR3-ANCA-associated crescentic glomerulonephritis in Japan.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21331743     DOI: 10.1007/s10157-011-0407-3

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  23 in total

1.  Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups.

Authors:  Herbert A Hauer; Ingeborg M Bajema; Hans C van Houwelingen; Franco Ferrario; Laure-Hélène Noël; Rüdiger Waldherr; David R W Jayne; Niels Rasmussen; Jan A Bruijn; E Christiaan Hagen
Journal:  Kidney Int       Date:  2002-01       Impact factor: 10.612

2.  [Guidelines for the management of rapidly progressive glomerulonephritis].

Authors:  Hideto Sakai; Kiyoshi Kurokawa; Akio Koyama; Yoshihiro Arimura; Hiroshi Kida; Hidekazu Shigematsu; Satoshi Suzuki; Hiroshi Nihei; Hirofumi Makino; Naohiko Ueda; Tetsuya Kawamura; Fumitake Gejyo; Takao Saito; Takashi Harada; Yoshijuki Hiki; Masahara Yoshida
Journal:  Nihon Jinzo Gakkai Shi       Date:  2002-03

3.  Cimetidine-induced tubulointerstitial nephritis with both MPO-ANCA and PR3-ANCA.

Authors:  Hideki Ueda; Eiji Ishimura; Takayuki Yunoki; Takao Tsuchida; Naoki Matsumoto; Syuichi Jono; Yasuo Imanishi; Masaaki Inaba; Yoshiki Nishizawa
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

4.  Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement.

Authors:  K W Westman; P G Bygren; H Olsson; J Ranstam; J Wieslander
Journal:  J Am Soc Nephrol       Date:  1998-05       Impact factor: 10.121

Review 5.  Outcome of ANCA-associated renal vasculitis: a 5-year retrospective study.

Authors:  Anthony D Booth; Mike K Almond; Aine Burns; Peter Ellis; Gill Gaskin; Guy H Neild; Martin Plaisance; Charles D Pusey; David R W Jayne
Journal:  Am J Kidney Dis       Date:  2003-04       Impact factor: 8.860

6.  Prognostic markers in patients with antineutrophil cytoplasmic autoantibody-associated microscopic polyangiitis and glomerulonephritis.

Authors:  S L Hogan; P H Nachman; A S Wilkman; J C Jennette; R J Falk
Journal:  J Am Soc Nephrol       Date:  1996-01       Impact factor: 10.121

7.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register.

Authors:  Eva Reinhold-Keller; Karen Herlyn; Rosemarie Wagner-Bastmeyer; Wolfgang L Gross
Journal:  Arthritis Rheum       Date:  2005-02-15

8.  Valvular injury in a patient with PR3-ANCA-associated glomerulonephritis.

Authors:  Hirotsugu Iwatani; Yasuyuki Nagasawa; Kazumasa Oka; Yoshitaka Isaka; Enyu Imai
Journal:  Nat Clin Pract Nephrol       Date:  2008-09-02

9.  Correlation of antineutrophil cytoplasmic antibodies with the extrarenal histopathology of Wegener's (pathergic) granulomatosis and related forms of vasculitis.

Authors:  R Fienberg; E J Mark; M Goodman; R T McCluskey; J L Niles
Journal:  Hum Pathol       Date:  1993-02       Impact factor: 3.466

Review 10.  ANCA-associated vasculitis: diagnosis, clinical characteristics and treatment.

Authors:  M Haubitz
Journal:  Vasa       Date:  2007-05       Impact factor: 1.961

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.